Author: Spokane Dermatology Clinic

Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

August 11, 2026
FDA Issues Complete Response Letter for AbbVie’s Fast-Acting Neurotoxin TrenibotE; Spokane dermatologist Dr. Philip Werschler on What the Letter Means

June 10, 2026

Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results